top of page
The COVID-19 Pandemic and Dimensions of Substance Use: A Narrative Review and Living Repository of Primary Data


3. Changes in drug markets
​

Limited data but some pointing toward:

  • Increased difficulty in obtaining drug of choice (dependent on the type of drug)

  • Increased costs

  • Decreased quality of drugs

  • It is difficult to attribute changes to the pandemic versus background drug market trends

Repository


 
Navigate to each dimension
 
  1. Changes in propensity to use substances
  2. Changes in substance use contexts and behaviors
  3. Changes in drug markets
  4. Association between substance use and the SARS-CoV-2 infection risk and COVID-19 severity
  5. Changes in healthcare and harm reduction service access among PWUD. 
bottom of page